Effect of ageing upon warfarin dose requirements: a longitudinal study

Area of Science:

• Pharmacology
• Gerontology
• Clinical Medicine

Background:

• Warfarin is a common anticoagulant used for thromboembolic disease prophylaxis.
• Understanding age-related changes in drug dosage is crucial for safe and effective patient management.

Purpose of the Study:

• To determine the rate of age-related changes in warfarin dose requirements.
• To investigate the longitudinal relationship between aging and warfarin dosage.

Main Methods:

• Retrospective analysis of warfarin dosage in 104 patients stabilized on therapy for a median of 10 years.
• Statistical correlation and regression analysis to assess dose changes over time and with age.

Main Results:

• A significant negative correlation was observed between initial warfarin dosage and patient age (p = 0.002, r = -0.30).
• Warfarin requirements decreased significantly over time, correlated with age differences (p = 0.01, r = 0.25).
• A projected 21% fall in warfarin requirements over 15 years was estimated.

Conclusions:

• Age-related decline in warfarin dose requirements is a significant factor in long-term anticoagulation therapy.
• Findings align with cross-sectional studies, indicating no major birth cohort effects.
• This study provides valuable insights for optimizing warfarin dosing strategies in aging populations.